Role of renal SGLT2 and SGLT1 in glucose reabsorption under normoglycaemic conditions and when SGLT2 is inhibited. https://t.co/x8WDaXFgwI https://t.co/HDVxdumTbE
First spend money on eating carbs, get metabolic disorders, then spend more money on SGLT2is... #lowcarb #IntermittentFasting
Brace up for the next gen Sglti Sglt1/2i Sglt1i part - reduces glucose absorption in the intertine Sglt2i part- reduces the re-absorption of Glucose at the Renal level Why ingest so much Glucose (carbohydrates) in the 1st place?? @dlifein @lowcarbGP h
Review & Perspective: Development of SGLT1 and SGLT2 inhibitors https://t.co/ulwRSizMy4
A review focussing on the rationale for the development of SGLT1 and SGLT2 inhibitors and dual SGLT1/2 inhibition, including aspects of genetics, genetically modified mouse models and mathematical modelling #type2diabetes #t2d https://t.co/RuJglkvAOF
RT @DiabetologiaJnl: A review focussing on the rationale for the development of SGLT1 and SGLT2 inhibitors and dual SGLT1/2 inhibition, inc…
RT @DiabetologiaJnl: A review focussing on the rationale for the development of SGLT1 and SGLT2 inhibitors and dual SGLT1/2 inhibition, inc…
A review focussing on the rationale for the development of SGLT1 and SGLT2 inhibitors and dual SGLT1/2 inhibition, including aspects of genetics, genetically modified mouse models and mathematical modelling #type2diabetes https://t.co/RuJglkNcdf
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
Development of SGLT1 and SGLT2 inhibitors. https://t.co/NuJQxJR02C
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
Nice review of the SGLT1&2 drugs in adults
VOLKER VALLON Again...
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
de nuevo Volker Vallon.....https://t.co/TYOk5z3ly7 https://t.co/axXa6jgNT5
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
RT @drjamesboyle: Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT…
Why target glucose handling in the kidney? Why target glucose handling in the intestine? Is it worth inhibiting both SGLT2 & SGLT1 in the kidney? This & more answered in this neat @DiabetologiaJnl review: Development of SGLT1 and SGLT2 inhibitors.